B01D9/005

Anion binding agent lithium salts for battery electrolytes

A method for synthesizing a purified lithium (Li).sup.+ anion binding agent (ABA-F).sup.− salt and the corresponding Li.sup.+(ABA-F).sup.− are disclosed. The method includes dissolving a boron-based acid in a polar solvent to form a solution. The solution is refluxed to form an anion binding agent. A stoichiometric amount of a small fluorinated salt, such as LiF, is added to the anion binding agent to form a mixture. The mixture is subsequently crystallized to obtain a substantially pure Li.sup.+(ABA-F).sup.− salt. Example purified Li.sup.+(ABA-F).sup.− salts include Ox-Li.sup.+(ABA-F), m-Li.sup.+(ABA-F), and BF.sub.3—Li.sup.+(ABA-F).sup.−. These purified Li.sup.+(ABA-F).sup.− salts provide the benefits of increased battery thermal safety without loss of electrochemical performance.

Permanent storage of carbon dioxide
20210114892 · 2021-04-22 ·

Disclosed is a method for fast and cost-efficient preparation of ikaite crystals. The method comprises contacting an alkaline aqueous solution, which comprises carbonate and bicarbonate ions, with a water solution, which comprises Ca.sup.2+, at a temperature not exceeding 15° C., wherein contact between the alkaline aqueous solution and the water solution takes place at a permeable or porous surface, through which either solution is fed to the other at a flow rate facilitating formation of ikaite crystals. Also disclosed is system for carrying out the ikaite preparation process. The process and system provides a cost efficient and effective means for capture and storage of carbon dioxide.

Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions

Polymorphic forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) and a metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) are disclosed and characterized. Compositions and method for treatment of Alzheimer's disease that includes the polymorphic forms and metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73).

METHOD FOR PURIFYING CRYSTALS USING SOLVENT VAPORS
20210107884 · 2021-04-15 ·

A Reflux Rinsing method for purifying crystals using solvent vapor through dynamic equilibrium recrystallization. Feed material having tetrahydrocannabinol (THC) is inserted into a reaction vessel having walls, and upper portion, and a lower portion with a bottom surface. The feed material is exposed to a hydrocarbon liquid in the reaction vessel in a quantity sufficient to keep liquid present in equilibrium with gas in the reaction vessel through the recrystallization process, forming a raw extract having THC. The walls and bottom surface of the reaction vessel are coated with raw extract. The reaction vessel is heated and then the heating is discontinued. Vapor/thin-film DER is promoted in the reaction vessel for a predetermined length of time with no solvent reflux, resulting in formation of purified crystals of THC acid under pressure. The hydrocarbon solvent is reclaimed from the reaction vessel, leaving the purified crystals and impurities. When the reaction vessel is opened, the purified crystals and impurities are removed.

Method for purifying an amino acid-n-carboxy anhydride

The present invention is a method for purifying an NCA, including the steps of: a) dissolving an NCA contaminated with impurities into a solvent which is a good solvent and is not a chlorinated solvent followed by stirring to precipitate an undissolved impurity to afford a suspension, b) adding an acidic filter aid having ability to trap a basic impurity to the obtained suspension followed by filtration and/or forming a fixed bed of the acidic filter aid having ability to trap a basic impurity followed by filtering the suspension to bring the suspension to be in contact with the acidic filter aid having ability to trap a basic impurity, and c) adding the obtained filtrate dropwise to a poor solvent for NCA to crystallize out the NCA in which the impurities are removed. This makes it possible to purify a low-purity NCA conveniently to afford a high-purity NCA.

METHOD FOR PRODUCING PARAFFIN WAX

Disclosed is a method for producing a paraffin wax, the method including a step of mixing an unrefined wax containing normal paraffin with a solvent of dipole term (p) is 4 to 8 and of hydrogen bonding term (h) is 3 to 10 of the Hansen Solubility Parameters, and obtaining a mixed liquid; and a step of separating a solid material from the mixed liquid and obtaining a paraffin wax in which the normal paraffin concentration is higher.

Heat storage apparatus, method for storing heat, and method for producing heat storage apparatus

A heat storage apparatus according to the present disclosure includes a heat storage material and a member. The heat storage material forms a clathrate hydrate by cooling. The member has a surface with a plurality of holes. In the case that the lattice constant of the clathrate hydrate is denoted by L and the outside diameter of a cage included in the clathrate hydrate is denoted by D, the plurality of holes are spaced at intervals of 1L to 10L, and each of the plurality of holes has a hole diameter of 1D to 20D.

Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posaconazole

The present invention provides an industrial method production of amorphous posaconazole. The present invention also relates to a method for production of the posaconazole via and novel crystalline forms of posaconazole intermediate. More particularly the present invention relates to novel crystalline forms of posaconazole intermediate and methods for production of novel crystalline forms of posaconazole intermediate represented by the following structural formula III Which is key intermediate in the production of posaconazole. The present invention also provides for the one pot process for the preparation of amorphous posaconazole using novel crystalline forms of benzyl posaconazole. ##STR00001##

METHOD AND DEVICE FOR CONTINUOUS SALT EXTRACTION FROM BRINE
20210047203 · 2021-02-18 ·

A water evaporation system includes an evaporation module configured to evaporate water from a brine; a support module attached to the evaporation module and configured to support the evaporation module above the brine; and an inlet configured to add a crystal growth inhibitor to the brine.

Process for preparation of boscalid anhydrate form I and boscalid anhydrate form II

The present invention relates to a novel process for preparation of boscalid anhydrate form I and boscalid anhydrate form II.